{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:22:52Z","timestamp":1759332172314},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1006\/gyno.1999.5612","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T21:31:24Z","timestamp":1033939884000},"page":"401-405","source":"Crossref","is-referenced-by-count":3,"title":["Role of TSG101 in Uterine Cervix Cancer"],"prefix":"10.1006","volume":"75","author":[{"given":"John D.","family":"O'Boyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monja L.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwun M.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.Michael","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn Y.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1999.5612_RF1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.1998.16.1.330","article-title":"Human papillomaviruses and associated malignancies","volume":"16","author":"Alani","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1999.5612_RF2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)81866-8","article-title":"The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer","volume":"88","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1006\/gyno.1999.5612_RF3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1006\/bbrc.1998.8547","article-title":"A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain","volume":"245","author":"Watanabe","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/gyno.1999.5612_RF4","first-page":"3131","article-title":"Aberrant splicing but not mutations of TSG101 in human breast cancer","volume":"57","author":"Lee","year":"1997","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5612_RF5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/sj.onc.1201591","article-title":"Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours","volume":"15","author":"Gayther","year":"1997","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5612_RF6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.onc.1202029","article-title":"TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer","volume":"17","author":"Oh","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5612_RF7","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/sj.onc.1201521","article-title":"Frequent abnormalities of TSG101 transcripts in human prostate cancer","volume":"15","author":"Sun","year":"1997","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5612_RF8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1071-5576(98)00018-5","article-title":"Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers","volume":"5","author":"Carney","year":"1998","journal-title":"J Soc Gynecol Invest"},{"key":"10.1006\/gyno.1999.5612_RF9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-2744(199812)23:4<195::AID-MC1>3.0.CO;2-G","article-title":"Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues","volume":"23","author":"Willeke","year":"1998","journal-title":"Mol Carcinog"},{"key":"10.1006\/gyno.1999.5612_RF10","first-page":"2256","article-title":"FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations","volume":"57","author":"Fong","year":"1997","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5612_RF11","first-page":"5128","article-title":"Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines","volume":"56","author":"Mao","year":"1996","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5612_RF12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jnci\/90.6.412","article-title":"Tumor suppressor genes: Does FHIT fit?","volume":"90","author":"Mao","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5612_RF13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/90.6.433","article-title":"Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: Association with human papillomavirus type [see comments]","volume":"90","author":"Muller","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1999.5612_RF14","unstructured":"Kingston, R, E, Preparation of RNA from eukaryotic and prokaryotic cells, in, Ausubel, F, M, Brent, R, Kingston, R, E, Moore, D, D, Seidman, J, G, Smith, J, A, (eds), Current Protocols in Molecular Biology, New York, Wiley, 1997"},{"key":"10.1006\/gyno.1999.5612_RF15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng0897-332","article-title":"Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer","volume":"16","author":"Steiner","year":"1997","journal-title":"Nature Genet"},{"key":"10.1006\/gyno.1999.5612_RF16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.onc.1201563","article-title":"Low frequency of TSG101\/CC2 gene alterations in invasive human breast cancers","volume":"16","author":"Wang","year":"1998","journal-title":"Oncogene"},{"key":"10.1006\/gyno.1999.5612_RF17","first-page":"4481","article-title":"Allelotype analysis of cervical carcinoma","volume":"54","author":"Mitra","year":"1994","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1999.5612_RF18","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/j.1460-2075.1986.tb04670.x","article-title":"Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells","volume":"5","author":"Saxon","year":"1986","journal-title":"EMBO J"},{"key":"10.1006\/gyno.1999.5612_RF19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mc.2940020103","article-title":"Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa","volume":"2","author":"Koi","year":"1989","journal-title":"Mol Carcinog"},{"key":"10.1006\/gyno.1999.5612_RF20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcb.240420304","article-title":"Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines","volume":"42","author":"Oshimura","year":"1990","journal-title":"J Cell Biochem"},{"key":"10.1006\/gyno.1999.5612_RF21","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.62.12.4538-4543.1988","article-title":"Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA","volume":"62","author":"Smits","year":"1988","journal-title":"J Virol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825899956123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T06:09:28Z","timestamp":1620022168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825899956123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S0090825899956123"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1999.5612","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}